OverviewChartNewsTraderScreen

Soc. Generale Knock-Out ROG/  DE000SF7UJK5  /

Frankfurt Zert./SG
1/9/2025  9:46:09 PM Chg.-0.380 Bid9:54:23 PM Ask9:54:23 PM Underlying Strike price Expiration date Option type
14.060EUR -2.63% 14.060
Bid Size: 750		 14.410
Ask Size: 750		 ROCHE GS 405.0159 CHF 12/31/2078 Put
TeleTrader 11/26/2024 Roche to buy Poseida Therapeutics for $1.5B
TeleTrader 10/23/2024 Roche's Q3 sales up 6% to 15.1B Swiss francs
Newsfile Corp 9/17/2024 Innovation Driving Cancer's Solid Tumors Market
GlobeNewswire 9/1/2024 Belite Bio Announces Appointment of Hendrik P. N. Scholl, MD, MA, as Chief Medical Officer
TeleTrader 7/25/2024 Europe lower premarket as earnings pour in
TeleTrader 7/25/2024 Roche's H1 sales at 29.85 billion Swiss francs
GlobeNewswire 6/13/2024 Pliant Therapeutics Announces Appointment of Steve Krognes to Board of Directors
GlobeNewswire 6/11/2024 Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D ...
TeleTrader 5/27/2024 Roche shuffles its executive committee
TeleTrader 5/16/2024 Roche notes progress in obesity drug trial
TeleTrader 4/24/2024 Roche's logs 14.4 billion Swiss francs in Q1 sales
TeleTrader 2/1/2024 Roche's 2023 sales increase 1% to 58.7B Swiss francs
TeleTrader 12/4/2023 Roche to buy Carmot Therapeutics for $2.7B
TeleTrader 10/23/2023 Roche to buy Telavant for $7.1 billion
TeleTrader 7/27/2023 Roche's sales fall 8% ito 29.8B Swiss francs in H1
TeleTrader 4/26/2023 Roche posts sales of 15.3B Swiss francs in Q1
TeleTrader 2/2/2023 Roche's 2022 sales stable at 63.28B Swiss francs
TeleTrader 12/12/2022 Roche Pharmaceuticals CEO leaves the company
TeleTrader 10/18/2022 Roche's sales down 6% to 14.7B Swiss francs in Q3
TeleTrader 7/21/2022 Roche's H1 group sales up 5% to 32.3B Swiss francs
TeleTrader 4/25/2022 Roche's Q1 sales up 11% to $17.17 billion
TeleTrader 2/3/2022 Europe opens mixed with ECB's interest rates call in focus
TeleTrader 2/3/2022 Roche's 2021 sales up by 8% to 62.8B Swiss francs
TeleTrader 12/27/2021 Switzerland approves use of Roche COVID treatment
TeleTrader 11/4/2021 Novartis to sell stake in Roche for $20.7 billion